Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MARK4 Antikörper (C-Term)

Verified MARK4 Reaktivität: Human, Maus ELISA, WB, FACS Wirt: Ziege Polyclonal unconjugated
Produktnummer ABIN184722
  • Target Alle MARK4 Antikörper anzeigen
    MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))
    Bindungsspezifität
    • 15
    • 10
    • 8
    • 8
    • 8
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 48
    • 43
    • 3
    Human, Maus
    Wirt
    • 61
    • 1
    Ziege
    Klonalität
    • 61
    • 1
    Polyklonal
    Konjugat
    • 22
    • 5
    • 5
    • 5
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MARK4 Antikörper ist unkonjugiert
    Applikation
    • 44
    • 34
    • 13
    • 13
    • 11
    • 7
    • 5
    • 3
    • 2
    • 2
    • 1
    ELISA, Western Blotting (WB), Flow Cytometry (FACS)
    Verwendungszweck
    MARK4L
    Sequenz
    IKRKPPPGCS DSPGV
    Spezifität
    This antibody is expected to recognize the reported long isoform 1 (NP_113605.2) only.
    Kreuzreaktivität
    Human, Maus
    Aufreinigung
    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
    Güteklasse
    Verified
    Immunogen
    Peptide with sequence IKRKPPPGCSDSPGV, from the C Terminus of the protein sequence according to NP_113605.2.
    Isotyp
    IgG
  • Applikationshinweise

    Western Blot: Approx 70 kDa band observed in Human Prostate lysates (calculated MW of 75.3 kDa according to NP_113605.2). Recommended concentration: 0.3-1 μg/mL.

    Peptide ELISA: antibody detection limit dilution 1:128000.

    Kommentare

    Flow Cytometry: Flow cytometric analysis of A431 cells. Recommended concentration: 10ug/ml.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Minimize freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
  • Target
    MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))
    Andere Bezeichnung
    MARK4 (MARK4 Produkte)
    Synonyme
    MARK4 antikoerper, MARK4L antikoerper, MARK4S antikoerper, MARKL1 antikoerper, MARKL1L antikoerper, PAR-1D antikoerper, 2410090P21Rik antikoerper, C79806 antikoerper, Markl1 antikoerper, microtubule affinity regulating kinase 4 antikoerper, MAP/microtubule affinity regulating kinase 4 antikoerper, MARK4 antikoerper, Mark4 antikoerper
    Hintergrund
    MARK4, MAP/microtubule affinity-regulating kinase 4, MARKL1, KIAA1860, Nbla00650, MARK4 serine/threonine protein kinase, MAP/microtubule affinity-regulating kinase like 1, FLJ90097, putative protein product of Nbla00650
    Gen-ID
    57787
    NCBI Accession
    NP_113605
Sie sind hier:
Kundenservice